Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1060

1.

FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study.

Vink FJ, Meijer CJLM, Clifford GM, Poljak M, Oštrbenk A, Petry KU, Rothe B, Bonde J, Pedersen H, de Sanjosé S, Torres M, Del Pino M, Quint WGV, Cuschieri K, Boada EA, van Trommel NE, Lissenberg-Witte BI, Floore AN, Hesselink AT, Steenbergen RDM, Bleeker MCG, Heideman DAM.

Int J Cancer. 2019 Aug 7. doi: 10.1002/ijc.32614. [Epub ahead of print]

PMID:
31390052
2.

The use of molecular markers for cervical screening of women living with HIV in South Africa.

Kremer WW, van Zummeren M, Breytenbach E, Richter KL, Steenbergen RDM, Meijer CJLM, Dreyer G.

AIDS. 2019 Nov 1;33(13):2035-2042. doi: 10.1097/QAD.0000000000002325.

PMID:
31385866
3.

Grading immunohistochemical markers p16INK4a and HPV E4 identifies productive and transforming lesions caused by low- and high-risk HPV within high-grade anal squamous intraepithelial lesions.

Leeman A, Jenkins D, Marra E, van Zummeren M, Pirog EC, van de Sandt MM, van Eeden A, Schim van der Loeff MF, Doorbar J, de Vries HJC, van Kemenade FJ, Meijer CJLM, Quint WGV.

Br J Dermatol. 2019 Jul 14. doi: 10.1111/bjd.18342. [Epub ahead of print]

PMID:
31302935
4.

Role of FAM19A4/miR124-2 methylation analysis in predicting regression or non-regression of CIN2/3 lesions: a protocol of an observational longitudinal cohort study.

Kremer WW, Berkhof J, Bleeker MC, Heideman DA, van Trommel NE, van Baal MW, Verhoeve HR, Meijer CJ, Kenter GG.

BMJ Open. 2019 Jul 9;9(7):e029017. doi: 10.1136/bmjopen-2019-029017.

5.

HPV infections and flat penile lesions of the penis in men who have sex with men.

Van Bilsen WPH, Kovaleva A, Bleeker MCG, King AJ, Bruisten SM, Brokking W, De Vries HJC, Meijer CJLM, Schim Van Der Loeff MF.

Papillomavirus Res. 2019 Jun 18;8:100173. doi: 10.1016/j.pvr.2019.100173. [Epub ahead of print]

6.

Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis.

Dick S, Kremer WW, De Strooper LMA, Lissenberg-Witte BI, Steenbergen RDM, Meijer CJLM, Berkhof J, Heideman DAM.

Gynecol Oncol. 2019 Aug;154(2):368-373. doi: 10.1016/j.ygyno.2019.06.002. Epub 2019 Jun 8.

PMID:
31182225
7.

Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands.

Polman NJ, de Haan Y, Veldhuijzen NJ, Heideman DAM, de Vet HCW, Meijer CJLM, Massuger LFAG, van Kemenade FJ, Berkhof J.

Prev Med. 2019 Aug;125:5-11. doi: 10.1016/j.ypmed.2019.04.025. Epub 2019 May 2.

PMID:
31054907
8.

Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling.

van Rooijen G, van Rooijen M, Maat A, Vermeulen JM, Meijer CJ, Ruhé HG, de Haan L; GROUP investigators; Genetic Risk and Outcome of Psychosis investigators:, Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, Delespaul P, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Amelsvoort T, van Haren NE, van Os J, van Winkel R.

Schizophr Res. 2019 Jun;208:82-89. doi: 10.1016/j.schres.2019.04.011. Epub 2019 Apr 29.

PMID:
31047723
9.

Obituary Peter Snijders.

Meijer CJLM; HPV Team.

Papillomavirus Res. 2019 Jan 9;7:43-44. doi: 10.1016/j.pvr.2019.01.001. [Epub ahead of print] No abstract available.

10.

HPV16 variant analysis in primary and recurrent CIN2/3 lesions demonstrates presence of the same consensus variant.

van der Weele P, King AJ, Meijer CJLM, Steenbergen RDM.

Papillomavirus Res. 2019 Jun;7:168-172. doi: 10.1016/j.pvr.2019.04.008. Epub 2019 Apr 13.

11.

Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.

Babion I, De Strooper LMA, Luttmer R, Bleeker MCG, Meijer CJLM, Heideman DAM, Wilting SM, Steenbergen RDM.

Epigenetics. 2019 Jun;14(6):558-567. doi: 10.1080/15592294.2019.1600390. Epub 2019 Apr 8.

12.

Effect of the bivalent HPV vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing and persistent infections in young Dutch females.

van der Weele P, Breeuwsma M, Donken R, van Logchem E, van Marm-Wattimena N, de Melker H, Meijer CJLM, King AJ.

PLoS One. 2019 Mar 4;14(3):e0212927. doi: 10.1371/journal.pone.0212927. eCollection 2019.

13.

Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial.

Polman NJ, Ebisch RMF, Heideman DAM, Melchers WJG, Bekkers RLM, Molijn AC, Meijer CJLM, Quint WGV, Snijders PJF, Massuger LFAG, van Kemenade FJ, Berkhof J.

Lancet Oncol. 2019 Feb;20(2):229-238. doi: 10.1016/S1470-2045(18)30763-0. Epub 2019 Jan 15.

PMID:
30658933
14.

HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme.

Polman NJ, Snijders PJF, Kenter GG, Berkhof J, Meijer CJLM.

Prev Med. 2019 Feb;119:108-117. doi: 10.1016/j.ypmed.2018.12.021. Epub 2018 Dec 27. Review.

15.

Management of HPV-positive women in cervical screening using results from two consecutive screening rounds.

Polman NJ, Veldhuijzen NJ, Heideman DAM, Snijders PJF, Meijer CJLM, Berkhof J.

Int J Cancer. 2019 May 1;144(9):2339-2346. doi: 10.1002/ijc.32004. Epub 2019 Jan 10.

PMID:
30565673
16.

HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.

Kremer WW, van Zummeren M, Heideman DAM, Lissenberg-Witte BI, Snijders PJF, Steenbergen RDM, Dreyer G, Meijer CJLM.

Int J Mol Sci. 2018 Oct 23;19(11). pii: E3297. doi: 10.3390/ijms19113297.

17.

Corrigendum to "Long-term course of negative symptom subdomains and relationship with outcome in patients with a psychotic disorder" [Schizophr. Res. 193 (2018) 173-181].

Stiekema APM, Islam MA, Liemburg EJ, Castelein S, van den Heuvel ER, van Weeghel J, Aleman A, Bruggeman R, van der Meer L; GROUP investigators, Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, de Haan L, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Haren NEM, van Os J, van Winkel R.

Schizophr Res. 2019 Feb;204:462-463. doi: 10.1016/j.schres.2018.10.003. Epub 2018 Oct 9. No abstract available.

PMID:
30314649
18.

Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation.

Leeman A, Ebisch RMF, Kasius A, Bosgraaf RP, Jenkins D, van de Sandt MM, de Strooper LMA, Heideman DAM, Snijders PJF, Massuger LFAG, Bekkers RLM, Meijer CJLM, van Kemenade FJ, Quint WGV, Melchers WJG.

Gynecol Oncol. 2018 Nov;151(2):311-318. doi: 10.1016/j.ygyno.2018.09.006. Epub 2018 Sep 13.

PMID:
30219239
19.

Genome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer.

Snoek BC, Verlaat W, Babion I, Novianti PW, van de Wiel MA, Wilting SM, van Trommel NE, Bleeker MCG, Massuger LFAG, Melchers WJG, Sie D, Heideman DAM, Snijders PJF, Meijer CJLM, Steenbergen RDM.

Int J Cancer. 2019 Jan 15;144(2):372-379. doi: 10.1002/ijc.31855. Epub 2018 Nov 4.

20.

Virological and Serological Predictors of Anal High-grade Squamous Intraepithelial Lesions Among Human Immunodeficiency Virus-positive Men Who Have Sex With Men.

Marra E, Siegenbeek van Heukelom ML, Leeman A, Waterboer T, Meijer CJLM, Snijders PJF, King AJ, Cairo I, van Eeden A, Brokking W, van der Weele P, Quint W, Prins JM, de Vries HJC, Schim van der Loeff MF.

Clin Infect Dis. 2019 Apr 8;68(8):1377-1387. doi: 10.1093/cid/ciy719.

PMID:
30165551
21.

HPV E4 expression and DNA hypermethylation of CADM1, MAL, and miR124-2 genes in cervical cancer and precursor lesions.

Zummeren MV, Kremer WW, Leeman A, Bleeker MCG, Jenkins D, Sandt MV, Doorbar J, Heideman DAM, Steenbergen RDM, Snijders PJF, Kenter GG, Quint WGV, Berkhof J, Meijer CJLM.

Mod Pathol. 2018 Dec;31(12):1842-1850. doi: 10.1038/s41379-018-0101-z. Epub 2018 Aug 22.

PMID:
30135508
22.

Detection of hypermethylated genes as markers for cervical screening in women living with HIV.

Kremer WW, Van Zummeren M, Novianti PW, Richter KL, Verlaat W, Snijders PJ, Heideman DA, Steenbergen RD, Dreyer G, Meijer CJ.

J Int AIDS Soc. 2018 Aug;21(8):e25165. doi: 10.1002/jia2.25165.

23.

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.

Leeman A, Del Pino M, Marimon L, Torné A, Ordi J, Ter Harmsel B, Meijer CJLM, Jenkins D, Van Kemenade FJ, Quint WGV.

Int J Cancer. 2019 Jan 1;144(1):160-168. doi: 10.1002/ijc.31787. Epub 2018 Nov 18.

24.

Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer.

Verlaat W, Van Leeuwen RW, Novianti PW, Schuuring E, Meijer CJLM, Van Der Zee AGJ, Snijders PJF, Heideman DAM, Steenbergen RDM, Wisman GBA.

Epigenetics. 2018;13(7):769-778. doi: 10.1080/15592294.2018.1507197. Epub 2018 Aug 24.

25.

Host Cell Deoxyribonucleic Acid Methylation Markers for the Detection of High-grade Anal Intraepithelial Neoplasia and Anal Cancer.

van der Zee RP, Richel O, van Noesel CJM, Novianti PW, Ciocanea-Teodorescu I, van Splunter AP, Duin S, van den Berk GEL, Meijer CJLM, Quint WGV, de Vries HJC, Prins JM, Steenbergen RDM.

Clin Infect Dis. 2019 Mar 19;68(7):1110-1117. doi: 10.1093/cid/ciy601.

26.

Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesis.

Swarts DRA, Voorham QJM, van Splunter AP, Wilting SM, Sie D, Pronk D, van Beurden M, Heideman DAM, Snijders PJF, Meijer CJLM, Steenbergen RDM, Bleeker MCG.

Cancer Med. 2018 Sep;7(9):4542-4553. doi: 10.1002/cam4.1633. Epub 2018 Jul 20.

27.

Three-tiered score for Ki-67 and p16ink4a improves accuracy and reproducibility of grading CIN lesions.

van Zummeren M, Leeman A, Kremer WW, Bleeker MCG, Jenkins D, van de Sandt M, Heideman DAM, Steenbergen R, Snijders PJF, Quint WGV, Berkhof J, Meijer CJLM.

J Clin Pathol. 2018 Nov;71(11):981-988. doi: 10.1136/jclinpath-2018-205271. Epub 2018 Jul 16.

28.

Human papillomavirus (HPV) prevalence and associated risk factors in women from Curaçao.

Hooi DJ, Lissenberg-Witte BI, Kenter G, de Koning MNC, Gomes Bravio I, Ardts K, Kleinmoedig S, Benita E, Pinedo HM, Berkhof J, Quint WGV, Meijer CJLM.

PLoS One. 2018 Jul 13;13(7):e0199624. doi: 10.1371/journal.pone.0199624. eCollection 2018.

29.

Human papillomavirus (HPV) types prevalence in cervical samples of female sex-workers on Curaçao.

Hooi DJ, Quint WGV, Lissenberg-Witte BI, Kenter G, Pinedo HM, de Koning MNC, Meijer CJLM.

Prev Med Rep. 2018 Jun 2;11:120-124. doi: 10.1016/j.pmedr.2018.06.001. eCollection 2018 Sep.

30.

Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study.

Babion I, Snoek BC, Novianti PW, Jaspers A, van Trommel N, Heideman DAM, Meijer CJLM, Snijders PJF, Steenbergen RDM, Wilting SM.

Clin Epigenetics. 2018 Jun 7;10:76. doi: 10.1186/s13148-018-0509-9. eCollection 2018.

31.

Associations between olfactory identification and (social) cognitive functioning: A cross-sectional study in schizophrenia patients and healthy controls.

de Nijs J, Meijer JH, de Haan L, Meijer CJ, Bruggeman R, van Haren NEM, Kahn RS, Cahn W.

Psychiatry Res. 2018 Aug;266:147-151. doi: 10.1016/j.psychres.2018.05.009. Epub 2018 May 19.

PMID:
29864614
32.

Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.

De Strooper LMA, Berkhof J, Steenbergen RDM, Lissenberg-Witte BI, Snijders PJF, Meijer CJLM, Heideman DAM.

Int J Cancer. 2018 Sep 15;143(6):1541-1548. doi: 10.1002/ijc.31539. Epub 2018 Apr 27.

33.

Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples.

Verlaat W, Snoek BC, Heideman DAM, Wilting SM, Snijders PJF, Novianti PW, van Splunter AP, Peeters CFW, van Trommel NE, Massuger LFAG, Bekkers RLM, Melchers WJG, van Kemenade FJ, Berkhof J, van de Wiel MA, Meijer CJLM, Steenbergen RDM.

Clin Cancer Res. 2018 Jul 15;24(14):3456-3464. doi: 10.1158/1078-0432.CCR-17-3615. Epub 2018 Apr 9.

34.

Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine.

Petry KU, Bollaerts K, Bonanni P, Stanley M, Drury R, Joura E, Kjaer SK, Meijer CJLM, Riethmuller D, Soubeyrand B, Van Damme P, Bosch X.

Hum Vaccin Immunother. 2018 Jul 3;14(7):1800-1806. doi: 10.1080/21645515.2018.1450125. Epub 2018 May 24.

35.

High Whole-Genome Sequence Diversity of Human Papillomavirus Type 18 Isolates.

van der Weele P, Meijer CJLM, King AJ.

Viruses. 2018 Feb 7;10(2). pii: E68. doi: 10.3390/v10020068.

36.

High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years After Vaccination in Young Dutch Women.

Donken R, King AJ, Bogaards JA, Woestenberg PJ, Meijer CJLM, de Melker HE.

J Infect Dis. 2018 Apr 23;217(10):1579-1589. doi: 10.1093/infdis/jiy067.

PMID:
29409034
37.

Supravaginal hysterectomy in Curaçao prevalence and impact on screening for cervical cancer.

Hooi DJ, Meijer CJLM, Witte BI, Bravio IG, Pinedo HM, Kenter GG.

Prev Med Rep. 2017 Nov 8;8:238-241. doi: 10.1016/j.pmedr.2017.11.005. eCollection 2017 Dec.

38.

High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.

Hooi DJ, Lissenberg-Witte BI, de Koning MNC, Pinedo HM, Kenter GG, Meijer CJ, Quint WG.

Sex Transm Infect. 2018 Jun;94(4):263-267. doi: 10.1136/sextrans-2017-053109. Epub 2017 Oct 11.

39.

Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel.

Polman NJ, Oštrbenk A, Xu L, Snijders PJF, Meijer CJLM, Poljak M, Heideman DAM, Arbyn M.

J Clin Microbiol. 2017 Dec;55(12):3544-3551. doi: 10.1128/JCM.01282-17. Epub 2017 Oct 11.

40.

HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test.

Polman NJ, Veldhuijzen NJ, Heideman DAM, Snijders PJF, Meijer CJLM, Berkhof J.

Br J Cancer. 2017 Nov 7;117(10):1557-1561. doi: 10.1038/bjc.2017.309. Epub 2017 Sep 7.

41.

An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibility.

Pos K, de Wit IE, van Dijk FA, Bartels-Velthuis AA, Bruggeman R, Meijer CJ, de Haan L; for Group; Genetic Risk and Outcome of Psychosis investigators, Alizadeh BZ, Bartels-Velthuis AA, Van Beveren NJ, Bruggeman R, Cahn W, de Haan L, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Haren NE, van Os J, van Winkel R.

Psychiatry Res. 2017 Dec;258:234-238. doi: 10.1016/j.psychres.2017.08.017. Epub 2017 Aug 18.

PMID:
28851542
42.

A state-independent network of depressive, negative and positive symptoms in male patients with schizophrenia spectrum disorders.

van Rooijen G, Isvoranu AM, Kruijt OH, van Borkulo CD, Meijer CJ, Wigman JTW, Ruhé HG, de Haan L; GROUP investigators.

Schizophr Res. 2018 Mar;193:232-239. doi: 10.1016/j.schres.2017.07.035. Epub 2017 Aug 23.

PMID:
28844638
43.

Metacognitive training in patients recovering from a first psychosis: an experience sampling study testing treatment effects.

Pos K, Meijer CJ, Verkerk O, Ackema O, Krabbendam L, de Haan L.

Eur Arch Psychiatry Clin Neurosci. 2018 Feb;268(1):57-64. doi: 10.1007/s00406-017-0833-7. Epub 2017 Aug 21.

44.

Longitudinal study of hippocampal volumes in heavy cannabis users.

Koenders L, Lorenzetti V, de Haan L, Suo C, Vingerhoets W, van den Brink W, Wiers RW, Meijer CJ, Machielsen M, Goudriaan AE, Veltman DJ, Yücel M, Cousijn J.

J Psychopharmacol. 2017 Aug;31(8):1027-1034. doi: 10.1177/0269881117718380. Epub 2017 Jul 25.

45.

Whole-Genome Sequencing and Variant Analysis of Human Papillomavirus 16 Infections.

van der Weele P, Meijer CJLM, King AJ.

J Virol. 2017 Sep 12;91(19). pii: e00844-17. doi: 10.1128/JVI.00844-17. Print 2017 Oct 1.

46.

Anal HPV 16 and 18 viral load: A comparison between HIV-negative and -positive MSM and association with persistence.

Marra E, King A, van Logchem E, van der Weele P, Mooij SH, Heijman T, Meijer CJLM, Verhagen DWM, van der Sande MAB, Schim van der Loeff MF.

J Med Virol. 2018 Jan;90(1):76-83. doi: 10.1002/jmv.24898. Epub 2017 Oct 17.

PMID:
28700080
47.

Selection of women at risk for cervical cancer in an HIV-infected South African population.

Van Zummeren M, Kremer WW, Van Aardt MC, Breytenbach E, Richter KL, Rozendaal L, Witte BI, De Strooper LMA, Hesselink AT, Heideman DAM, Snijders PJF, Steenbergen RDM, Dreyer G, Meijer CJLM.

AIDS. 2017 Sep 10;31(14):1945-1953. doi: 10.1097/QAD.0000000000001583.

PMID:
28692545
48.

Stratifying HPV-positive women for CIN3+ risk after one and two rounds of HPV-based screening.

Veldhuijzen NJ, Polman NJ, Snijders PJF, Meijer CJLM, Berkhof J.

Int J Cancer. 2017 Oct 15;141(8):1551-1560. doi: 10.1002/ijc.30865. Epub 2017 Jul 18.

49.

Human Papillomavirus Triage of Women With Atypical Squamous Cells of Undetermined Significance-Reduction of Overtreatment Needed.

Meijer CJLM, Snijders PJF.

JAMA Oncol. 2017 Oct 1;3(10):1310-1311. doi: 10.1001/jamaoncol.2017.1522. No abstract available.

PMID:
28654967
50.

Dopamine D2-receptor affinity of antipsychotics in relation to subjective well-being in patients with a psychotic disorder.

de Wit IE, van Dijk FA, Meijer CJ, van Tricht MJ, de Haan L; for GROUP.

Int Clin Psychopharmacol. 2017 Sep;32(5):249-255. doi: 10.1097/YIC.0000000000000182.

PMID:
28542034

Supplemental Content

Loading ...
Support Center